Ironwood Pharmaceuticals
IRWD
$6.30
Share price
3.96%
Change (1 day)
-42.10%
Change (1 year)
Categories
Ironwood Pharmaceuticals (IRWD) - P/B ratio
P/B ratio as of June 2024 : -2.91
According to Ironwood Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of -2.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ironwood Pharmaceuticals - P/B ratio (from 2010 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -5.16 | -277.04% |
| 2022-12-31 | 2.91 | -7.49% |
| 2021-12-31 | 3.15 | -89.18% |
| 2020-12-31 | 29.1 | -229.46% |
| 2019-12-31 | -22.5 | 176.02% |
| 2018-12-31 | -8.15 | -103.95% |
| 2017-12-31 | 206 | 585.59% |
| 2016-12-31 | 30.1 | 93.7% |
| 2015-12-31 | 15.5 | -28.19% |
| 2014-12-31 | 21.6 | -30.79% |
| 2013-12-31 | 31.2 | 418.76% |
| 2012-12-31 | 6.02 | -7.74% |
| 2011-12-31 | 6.52 | 108.65% |
| 2010-12-31 | 3.13 | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | 6.35 | -317.88% | 🇬🇧 UK |
 Nektar Therapeutics
NKTR | 1.99 | -168.12% | 🇺🇸 USA |